The global Oligonucleotide Therapy market was valued at US$ 3678.1 million in 2023 and is anticipated to reach US$ 4746.7 million by 2030, witnessing a CAGR of 3.6% during the forecast period 2024-2030.

Oligonucleotide Therapy Market

Many pharmaceutical companies were conducting research on oligonucleotide therapy, which employs chemically synthesized nucleotide-like small molecule drugs with potential specificity similar to that of therapeutic antibodies.

Although several types of oligonucleotide therapies exist, five of them are compared here, including the ones targeting nucleic acids (such as mRNA) or proteins, as well as others intended for stimulation of the immune system. DDS is generally used with oligonucleotide therapy, as it is difficult for these molecules to penetrate cell membrane when administered on their own.

Biogen is the industry's biggest player, with more than 76 percent of 2018 revenue, followed by Sarepta Therapeutics and Jazz Pharmaceuticals, with 13.35 percent and 6.63 percent, respectively. North America and Europe are the most important regions, accounting for more than 80 percent of the combined income.

This report aims to provide a comprehensive presentation of the global market for Oligonucleotide Therapy, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Oligonucleotide Therapy.

Report Scope

The Oligonucleotide Therapy market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Oligonucleotide Therapy market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Oligonucleotide Therapy companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

Scope of Oligonucleotide Therapy Market Report

Report Metric	Details
Report Name	Oligonucleotide Therapy Market
Accounted market size in 2023	US$ 3678.1 million
Forecasted market size in 2030	US$ 4746.7 million
CAGR	3.6%
Base Year	2023
Forecasted years	2024 - 2030
Segment by Type	Antisense Oligonucleotide Aptamer Others
Segment by Application	Infectious Diseases Oncology Neurodegenerative Disorders Cardiovascular Diseases Kidney Diseases Others
By Region	North America (United States, Canada) Europe (Germany, France, UK, Italy, Russia) Rest of Europe Nordic Countries Asia-Pacific (China, Japan, South Korea) Southeast Asia (India, Australia) Rest of Asia Latin America (Mexico, Brazil) Rest of Latin America Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company	Alnylam Pharmaceuticals Inc., Biogen, Dynavax Technologies Corp., Merck and Co., Miragen Therapeuutics Inc., Sarepta Therapeutics Inc., GlaxoSmithKline, Pfizer, Gilead Sciences
Forecast units	USD million in value
Report coverage	Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter 3: Detailed analysis of Oligonucleotide Therapy companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.
Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.
Chapter 12: The main points and conclusions of the report.

FAQ for this report

How fast is Oligonucleotide Therapy Market growing?

Ans: The Oligonucleotide Therapy Market witnessing a CAGR of 3.6% during the forecast period 2024-2030.

What is the Oligonucleotide Therapy Market size in 2030?

Ans: The Oligonucleotide Therapy Market size in 2030 will be US$ 4746.7 million.

Who are the main players in the Oligonucleotide Therapy Market report?

Ans: The main players in the Oligonucleotide Therapy Market are Alnylam Pharmaceuticals Inc., Biogen, Dynavax Technologies Corp., Merck and Co., Miragen Therapeuutics Inc., Sarepta Therapeutics Inc., GlaxoSmithKline, Pfizer, Gilead Sciences

What are the Application segmentation covered in the Oligonucleotide Therapy Market report?

Ans: The Applications covered in the Oligonucleotide Therapy Market report are Infectious Diseases, Oncology, Neurodegenerative Disorders, Cardiovascular Diseases, Kidney Diseases, Others

What are the Type segmentation covered in the Oligonucleotide Therapy Market report?

Ans: The Types covered in the Oligonucleotide Therapy Market report are Antisense Oligonucleotide, Aptamer, Others

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Oligonucleotide Therapy Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 Antisense Oligonucleotide

1.2.3 Aptamer

1.2.4 Others

1.3 Market by Application

1.3.1 Global Oligonucleotide Therapy Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Infectious Diseases

1.3.3 Oncology

1.3.4 Neurodegenerative Disorders

1.3.5 Cardiovascular Diseases

1.3.6 Kidney Diseases

1.3.7 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Oligonucleotide Therapy Market Perspective (2019-2030)

2.2 Oligonucleotide Therapy Growth Trends by Region

2.2.1 Global Oligonucleotide Therapy Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Oligonucleotide Therapy Historic Market Size by Region (2019-2024)

2.2.3 Oligonucleotide Therapy Forecasted Market Size by Region (2025-2030)

2.3 Oligonucleotide Therapy Market Dynamics

2.3.1 Oligonucleotide Therapy Industry Trends

2.3.2 Oligonucleotide Therapy Market Drivers

2.3.3 Oligonucleotide Therapy Market Challenges

2.3.4 Oligonucleotide Therapy Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Oligonucleotide Therapy Players by Revenue

3.1.1 Global Top Oligonucleotide Therapy Players by Revenue (2019-2024)

3.1.2 Global Oligonucleotide Therapy Revenue Market Share by Players (2019-2024)

3.2 Global Oligonucleotide Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Oligonucleotide Therapy Revenue

3.4 Global Oligonucleotide Therapy Market Concentration Ratio

3.4.1 Global Oligonucleotide Therapy Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Oligonucleotide Therapy Revenue in 2023

3.5 Oligonucleotide Therapy Key Players Head office and Area Served

3.6 Key Players Oligonucleotide Therapy Product Solution and Service

3.7 Date of Enter into Oligonucleotide Therapy Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Oligonucleotide Therapy Breakdown Data by Type

4.1 Global Oligonucleotide Therapy Historic Market Size by Type (2019-2024)

4.2 Global Oligonucleotide Therapy Forecasted Market Size by Type (2025-2030)

5 Oligonucleotide Therapy Breakdown Data by Application

5.1 Global Oligonucleotide Therapy Historic Market Size by Application (2019-2024)

5.2 Global Oligonucleotide Therapy Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Oligonucleotide Therapy Market Size (2019-2030)

6.2 North America Oligonucleotide Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Oligonucleotide Therapy Market Size by Country (2019-2024)

6.4 North America Oligonucleotide Therapy Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Oligonucleotide Therapy Market Size (2019-2030)

7.2 Europe Oligonucleotide Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Oligonucleotide Therapy Market Size by Country (2019-2024)

7.4 Europe Oligonucleotide Therapy Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Oligonucleotide Therapy Market Size (2019-2030)

8.2 Asia-Pacific Oligonucleotide Therapy Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Oligonucleotide Therapy Market Size by Region (2019-2024)

8.4 Asia-Pacific Oligonucleotide Therapy Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Oligonucleotide Therapy Market Size (2019-2030)

9.2 Latin America Oligonucleotide Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Oligonucleotide Therapy Market Size by Country (2019-2024)

9.4 Latin America Oligonucleotide Therapy Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Oligonucleotide Therapy Market Size (2019-2030)

10.2 Middle East & Africa Oligonucleotide Therapy Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Oligonucleotide Therapy Market Size by Country (2019-2024)

10.4 Middle East & Africa Oligonucleotide Therapy Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 Alnylam Pharmaceuticals Inc.

11.1.1 Alnylam Pharmaceuticals Inc. Company Detail

11.1.2 Alnylam Pharmaceuticals Inc. Business Overview

11.1.3 Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Introduction

11.1.4 Alnylam Pharmaceuticals Inc. Revenue in Oligonucleotide Therapy Business (2019-2024)

11.1.5 Alnylam Pharmaceuticals Inc. Recent Development

11.2 Biogen

11.2.1 Biogen Company Detail

11.2.2 Biogen Business Overview

11.2.3 Biogen Oligonucleotide Therapy Introduction

11.2.4 Biogen Revenue in Oligonucleotide Therapy Business (2019-2024)

11.2.5 Biogen Recent Development

11.3 Dynavax Technologies Corp.

11.3.1 Dynavax Technologies Corp. Company Detail

11.3.2 Dynavax Technologies Corp. Business Overview

11.3.3 Dynavax Technologies Corp. Oligonucleotide Therapy Introduction

11.3.4 Dynavax Technologies Corp. Revenue in Oligonucleotide Therapy Business (2019-2024)

11.3.5 Dynavax Technologies Corp. Recent Development

11.4 Merck and Co.

11.4.1 Merck and Co. Company Detail

11.4.2 Merck and Co. Business Overview

11.4.3 Merck and Co. Oligonucleotide Therapy Introduction

11.4.4 Merck and Co. Revenue in Oligonucleotide Therapy Business (2019-2024)

11.4.5 Merck and Co. Recent Development

11.5 Miragen Therapeuutics Inc.

11.5.1 Miragen Therapeuutics Inc. Company Detail

11.5.2 Miragen Therapeuutics Inc. Business Overview

11.5.3 Miragen Therapeuutics Inc. Oligonucleotide Therapy Introduction

11.5.4 Miragen Therapeuutics Inc. Revenue in Oligonucleotide Therapy Business (2019-2024)

11.5.5 Miragen Therapeuutics Inc. Recent Development

11.6 Sarepta Therapeutics Inc.

11.6.1 Sarepta Therapeutics Inc. Company Detail

11.6.2 Sarepta Therapeutics Inc. Business Overview

11.6.3 Sarepta Therapeutics Inc. Oligonucleotide Therapy Introduction

11.6.4 Sarepta Therapeutics Inc. Revenue in Oligonucleotide Therapy Business (2019-2024)

11.6.5 Sarepta Therapeutics Inc. Recent Development

11.7 GlaxoSmithKline

11.7.1 GlaxoSmithKline Company Detail

11.7.2 GlaxoSmithKline Business Overview

11.7.3 GlaxoSmithKline Oligonucleotide Therapy Introduction

11.7.4 GlaxoSmithKline Revenue in Oligonucleotide Therapy Business (2019-2024)

11.7.5 GlaxoSmithKline Recent Development

11.8 Pfizer

11.8.1 Pfizer Company Detail

11.8.2 Pfizer Business Overview

11.8.3 Pfizer Oligonucleotide Therapy Introduction

11.8.4 Pfizer Revenue in Oligonucleotide Therapy Business (2019-2024)

11.8.5 Pfizer Recent Development

11.9 Gilead Sciences

11.9.1 Gilead Sciences Company Detail

11.9.2 Gilead Sciences Business Overview

11.9.3 Gilead Sciences Oligonucleotide Therapy Introduction

11.9.4 Gilead Sciences Revenue in Oligonucleotide Therapy Business (2019-2024)

11.9.5 Gilead Sciences Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

FEATURED COMPANIES

Alnylam Pharmaceuticals Inc

Dynavax Technologies Corp

Merck and Co.

Miragen Therapeuutics Inc.

Sarepta Therapeutics Inc

GlaxoSmithKline PLC

Pfizer Inc

Gilead Sciences

List of Tables

Table 1. Global Oligonucleotide Therapy Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of Antisense Oligonucleotide

Table 3. Key Players of Aptamer

Table 4. Key Players of Others

Table 5. Global Oligonucleotide Therapy Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 6. Global Oligonucleotide Therapy Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Oligonucleotide Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 8. Global Oligonucleotide Therapy Market Share by Region (2019-2024)

Table 9. Global Oligonucleotide Therapy Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 10. Global Oligonucleotide Therapy Market Share by Region (2025-2030)

Table 11. Oligonucleotide Therapy Market Trends

Table 12. Oligonucleotide Therapy Market Drivers

Table 13. Oligonucleotide Therapy Market Challenges

Table 14. Oligonucleotide Therapy Market Restraints

Table 15. Global Oligonucleotide Therapy Revenue by Players (2019-2024) & (US$ Million)

Table 16. Global Oligonucleotide Therapy Market Share by Players (2019-2024)

Table 17. Global Top Oligonucleotide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapy as of 2023)

Table 18. Ranking of Global Top Oligonucleotide Therapy Companies by Revenue (US$ Million) in 2023

Table 19. Global 5 Largest Players Market Share by Oligonucleotide Therapy Revenue (CR5 and HHI) & (2019-2024)

Table 20. Key Players Headquarters and Area Served

Table 21. Key Players Oligonucleotide Therapy Product Solution and Service

Table 22. Date of Enter into Oligonucleotide Therapy Market

Table 23. Mergers & Acquisitions, Expansion Plans

Table 24. Global Oligonucleotide Therapy Market Size by Type (2019-2024) & (US$ Million)

Table 25. Global Oligonucleotide Therapy Revenue Market Share by Type (2019-2024)

Table 26. Global Oligonucleotide Therapy Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 27. Global Oligonucleotide Therapy Revenue Market Share by Type (2025-2030)

Table 28. Global Oligonucleotide Therapy Market Size by Application (2019-2024) & (US$ Million)

Table 29. Global Oligonucleotide Therapy Revenue Market Share by Application (2019-2024)

Table 30. Global Oligonucleotide Therapy Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 31. Global Oligonucleotide Therapy Revenue Market Share by Application (2025-2030)

Table 32. North America Oligonucleotide Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 33. North America Oligonucleotide Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 34. North America Oligonucleotide Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 35. Europe Oligonucleotide Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 36. Europe Oligonucleotide Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 37. Europe Oligonucleotide Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 38. Asia-Pacific Oligonucleotide Therapy Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 39. Asia-Pacific Oligonucleotide Therapy Market Size by Region (2019-2024) & (US$ Million)

Table 40. Asia-Pacific Oligonucleotide Therapy Market Size by Region (2025-2030) & (US$ Million)

Table 41. Latin America Oligonucleotide Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 42. Latin America Oligonucleotide Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 43. Latin America Oligonucleotide Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 44. Middle East & Africa Oligonucleotide Therapy Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 45. Middle East & Africa Oligonucleotide Therapy Market Size by Country (2019-2024) & (US$ Million)

Table 46. Middle East & Africa Oligonucleotide Therapy Market Size by Country (2025-2030) & (US$ Million)

Table 47. Alnylam Pharmaceuticals Inc. Company Detail

Table 48. Alnylam Pharmaceuticals Inc. Business Overview

Table 49. Alnylam Pharmaceuticals Inc. Oligonucleotide Therapy Product

Table 50. Alnylam Pharmaceuticals Inc. Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 51. Alnylam Pharmaceuticals Inc. Recent Development

Table 52. Biogen Company Detail

Table 53. Biogen Business Overview

Table 54. Biogen Oligonucleotide Therapy Product

Table 55. Biogen Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 56. Biogen Recent Development

Table 57. Dynavax Technologies Corp. Company Detail

Table 58. Dynavax Technologies Corp. Business Overview

Table 59. Dynavax Technologies Corp. Oligonucleotide Therapy Product

Table 60. Dynavax Technologies Corp. Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 61. Dynavax Technologies Corp. Recent Development

Table 62. Merck and Co. Company Detail

Table 63. Merck and Co. Business Overview

Table 64. Merck and Co. Oligonucleotide Therapy Product

Table 65. Merck and Co. Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 66. Merck and Co. Recent Development

Table 67. Miragen Therapeuutics Inc. Company Detail

Table 68. Miragen Therapeuutics Inc. Business Overview

Table 69. Miragen Therapeuutics Inc. Oligonucleotide Therapy Product

Table 70. Miragen Therapeuutics Inc. Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 71. Miragen Therapeuutics Inc. Recent Development

Table 72. Sarepta Therapeutics Inc. Company Detail

Table 73. Sarepta Therapeutics Inc. Business Overview

Table 74. Sarepta Therapeutics Inc. Oligonucleotide Therapy Product

Table 75. Sarepta Therapeutics Inc. Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 76. Sarepta Therapeutics Inc. Recent Development

Table 77. GlaxoSmithKline Company Detail

Table 78. GlaxoSmithKline Business Overview

Table 79. GlaxoSmithKline Oligonucleotide Therapy Product

Table 80. GlaxoSmithKline Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 81. GlaxoSmithKline Recent Development

Table 82. Pfizer Company Detail

Table 83. Pfizer Business Overview

Table 84. Pfizer Oligonucleotide Therapy Product

Table 85. Pfizer Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 86. Pfizer Recent Development

Table 87. Gilead Sciences Company Detail

Table 88. Gilead Sciences Business Overview

Table 89. Gilead Sciences Oligonucleotide Therapy Product

Table 90. Gilead Sciences Revenue in Oligonucleotide Therapy Business (2019-2024) & (US$ Million)

Table 91. Gilead Sciences Recent Development

Table 92. Research Programs/Design for This Report

Table 93. Key Data Information from Secondary Sources

Table 94. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Oligonucleotide Therapy Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Oligonucleotide Therapy Market Share by Type: 2023 VS 2030

Figure 3. Antisense Oligonucleotide Features

Figure 4. Aptamer Features

Figure 5. Others Features

Figure 6. Global Oligonucleotide Therapy Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 7. Global Oligonucleotide Therapy Market Share by Application: 2023 VS 2030

Figure 8. Infectious Diseases Case Studies

Figure 9. Oncology Case Studies

Figure 10. Neurodegenerative Disorders Case Studies

Figure 11. Cardiovascular Diseases Case Studies

Figure 12. Kidney Diseases Case Studies

Figure 13. Others Case Studies

Figure 14. Oligonucleotide Therapy Report Years Considered

Figure 15. Global Oligonucleotide Therapy Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 16. Global Oligonucleotide Therapy Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 17. Global Oligonucleotide Therapy Market Share by Region: 2023 VS 2030

Figure 18. Global Oligonucleotide Therapy Market Share by Players in 2023

Figure 19. Global Top Oligonucleotide Therapy Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Oligonucleotide Therapy as of 2023)

Figure 20. The Top 10 and 5 Players Market Share by Oligonucleotide Therapy Revenue in 2023

Figure 21. North America Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. North America Oligonucleotide Therapy Market Share by Country (2019-2030)

Figure 23. United States Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Canada Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 25. Europe Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. Europe Oligonucleotide Therapy Market Share by Country (2019-2030)

Figure 27. Germany Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. France Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. U.K. Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Italy Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Russia Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Nordic Countries Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 33. Asia-Pacific Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Asia-Pacific Oligonucleotide Therapy Market Share by Region (2019-2030)

Figure 35. China Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Japan Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. South Korea Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Southeast Asia Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. India Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Australia Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 41. Latin America Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Latin America Oligonucleotide Therapy Market Share by Country (2019-2030)

Figure 43. Mexico Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Brazil Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 45. Middle East & Africa Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Middle East & Africa Oligonucleotide Therapy Market Share by Country (2019-2030)

Figure 47. Turkey Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 48. Saudi Arabia Oligonucleotide Therapy Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 49. Alnylam Pharmaceuticals Inc. Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 50. Biogen Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 51. Dynavax Technologies Corp. Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 52. Merck and Co. Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 53. Miragen Therapeuutics Inc. Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 54. Sarepta Therapeutics Inc. Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 55. GlaxoSmithKline Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 56. Pfizer Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 57. Gilead Sciences Revenue Growth Rate in Oligonucleotide Therapy Business (2019-2024)

Figure 58. Bottom-up and Top-down Approaches for This Report

Figure 59. Data Triangulation

Figure 60. Key Executives Interviewed

SELECT A FORMAT

Added to Cart

Single User

Electronic (PDF)

$2900

This license allows only one user to access the PDF.

Multi User

Electronic (PDF)

$4350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together

Enterprise User

Electronic (PDF)

$5800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report

Add to Cart

Buy Now (15% Discount)

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

SIMILAR REPORTS

RELATED REPORTS

Global Genome Engineering Editing Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-34Q14901

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Nasal Administration Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-12L16880

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Pharmaceutical Ggrade Probiotics Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-32O11372

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

Global Rapid Diagnostic Reagent Filler Market Research Report 2024

120 Pages

Type: Report

Code: QYRE-Auto-38K13957

Fri Oct 04 00:00:00 UTC 2024

Add to Cart

aluates Reports

Support Contacts

U.S. (TOLL FREE)

+1 (425) 388-2538

sales@valuates.com

THE COMPANY

OUR PRODUCTS

CUSTOMER SUPPORT

CONTACT
FAQ

POLICES

THE COMPANY

ABOUT US

CUSTOMER SUPPORT

CONTACT
FAQ

OUR PRODUCTS

POLICES

Sitemap - Privacy Policy - Terms & Conditions